C

Cooper University Health Care | Internal Medicine Department

Research site
(Unclaimed)
Location
1 Cooper Plaza, Camden, New Jersey, United States of America

Site insights

Top conditions

Top treatments

Lidocaine
ABBV-382
Budigalimab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

2 of 5 total trials

A Study to Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion of Budigalimab and/or ABBV-382

Human immuno-deficiency virus (HIV) is the virus that causes Acquired Immuno-Deficiency Syndrome (AIDS). HIV disease is considered to be a chronic di...

Enrolling
Human Immuno-deficiency Virus (HIV) Disease
Drug: Budigalimab
Drug: ABBV-382

The trial is designed to assess the safety and efficacy of using the Zoom Reperfusion System in subjects diagnosed with acute ischemic stroke and und...

Enrolling
Ischemic Stroke
Acute Stroke
Device: Zoom Reperfusion System

Trial sponsors

AbbVie logo
Boston Medical Center (BMC) logo
Cooper University Health Care logo
I
M

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems